References
- Bunt SK, Sinha P, Clements VK, et al (2006). Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol, 176, 284-90. https://doi.org/10.4049/jimmunol.176.1.284
- Cai W, Qin A, Guo P, et al (2013). Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J Clin Immunol, 33, 798-808. https://doi.org/10.1007/s10875-012-9861-2
- Crawford A, Wherry EJ (2009). The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol, 21, 179-86. https://doi.org/10.1016/j.coi.2009.01.010
- Dmitry I, Gabrilovich, Srinivas Nagaraj (2009). Myeloidderived-suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74. https://doi.org/10.1038/nri2506
- European Association for the Study of the Liver (2012). EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatology, 57, 167-85. https://doi.org/10.1016/j.jhep.2012.02.010
- Gabrilovieh DI, Nagaraj S (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74. https://doi.org/10.1038/nri2506
- Greten TF, Manns MP, Korangy F,et al (2011). Myeloid derived suppressor cells in human diseases. Int Immunopharmacol, 11, 802-7. https://doi.org/10.1016/j.intimp.2011.01.003
- Hakan A, Ozturk O, Binnur K, et al (2013). Prevalence of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population. Asian Pac J Cancer Prev, 14, 5489-94. https://doi.org/10.7314/APJCP.2013.14.9.5489
- Ito K, Kim KH, Lok AS, et aL (2009). Characterization ofgenotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigenprecursor and identification offurin as the candidate enzyme. J Virol, 83, 3507-17. https://doi.org/10.1128/JVI.02348-08
- Lathers DM, Clark JI, Achille NJ, et al (2004). Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol Immunother, 53, 422-30. https://doi.org/10.1007/s00262-003-0459-7
- Li L, Wu B, Yang LB, et al (2013). Chronic hepatitis b virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 275-9. https://doi.org/10.7314/APJCP.2013.14.1.275
- Lim YS, Han S, Heo NY, et al (2014). Liver Transplantation, and Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Treated with Entecavir vs Lamivudine. Gastroenterol, 25.
- Martin F, Apetoh L, Ghiringhelli F (2012). Role of myeloidderived suppressor cells in tumor immunotherapy. Immunotherapy, 4, 43-57. https://doi.org/10.2217/imt.11.154
- Milich D, Liang TJ (2003). Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology, 38, 1075-86. https://doi.org/10.1053/jhep.2003.50453
- Peranzoni E, Zilio S, Marigo I, et al (2010). Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol, 22, 238-44. https://doi.org/10.1016/j.coi.2010.01.021
- Qin A, Cai W, Pan T, et al (2013). Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositiveindividuals. J Virol, 87, 1477-90. https://doi.org/10.1128/JVI.01759-12
- Qu P, Boelte KC, Lin PC (2012). Negative regulation of myeloid-derived suppressor cells in cancer. Immunol Invest, 41, 562-80. https://doi.org/10.3109/08820139.2012.685538
- Revill P, Yuen L, Walsh R, et a1 (2010). Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. J Med Virol, 82, 104-15. https://doi.org/10.1002/jmv.21645
- Serafini P, Borrello I, Bronte V, et al (2006). Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol, 16, 53-65. https://doi.org/10.1016/j.semcancer.2005.07.005
- Suzuki E, Kapoor V, Jassar AS, et al (2005). Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res, 11, 6713-21. https://doi.org/10.1158/1078-0432.CCR-05-0883
- Tacke RS, Lee HC, Goh C, et al (2012). Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production ofreactive oxygenspecies. Hepatology, 55, 343-53. https://doi.org/10.1002/hep.24700
- Tinoco R, Alcalde V, Yang Y, et a1 (2009). Cell-intrinsic transforming growth factor-beta signaling mediates virusspecific CD8+T cell deletion and viral persistence in vivo. Immunity, 31, 145-57. https://doi.org/10.1016/j.immuni.2009.06.015
- Vollbrecht T, Stirner R, Tufman A, et al (2012). Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS, 26, 31-7. https://doi.org/10.1097/QAD.0b013e3283558446
- Wang FS, Zhang Z (2009). Host immunity influences disease progression and antiviral efficacy in humansinfected with hepatitis B virus. Expert Rev Gastroenterol Hepatol, 3, 499-512. https://doi.org/10.1586/egh.09.50
- Yu M, Niu ZM, Wei YQ (2013). Effective response of the peritoneum microenvironment to peritoneal and systemic metastasis from colorectal carcinoma. Asian Pac J Cancer Prev, 14, 7289-94. https://doi.org/10.7314/APJCP.2013.14.12.7289
Cited by
- Chronic hepatitis B surface antigen seroclearance-related immune factors vol.47, pp.1, 2016, https://doi.org/10.1111/hepr.12726
- Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute Friend retrovirus infection vol.14, pp.1, 2017, https://doi.org/10.1186/s12977-017-0364-3
- The Role of Myeloid-Derived Suppressor Cells in Viral Infection vol.30, pp.2, 2017, https://doi.org/10.1089/vim.2016.0125
- Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs vol.16, pp.2, 2015, https://doi.org/10.3390/ijms16023307